¼¼°èÀÇ °í¾çÀÌ ¹é½Å ½ÃÀå
Cat Vaccines
»óǰÄÚµå : 1774695
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 466 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°í¾çÀÌ ¹é½Å ¼¼°è ½ÃÀåÀº 2030³â±îÁö 17¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °í¾çÀÌ ¹é½Å ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 8.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °³·®/¾àµ¶È­ »ý¹é½ÅÀº CAGR 9.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 9¾ï 6,510¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºÒȰȭ ¹é½Å ºÐ¾ß ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 2¾ï 9,080¸¸ ´Þ·¯, Áß±¹Àº CAGR 12.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °í¾çÀÌ ¹é½Å ½ÃÀåÀº 2024³â¿¡ 2¾ï 9,080¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 12.8%·Î 2030³â±îÁö 3¾ï 6,970¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.0%¿Í 7.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °í¾çÀÌ ¹é½Å ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°í¾çÀÌ ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

°í¾çÀÌ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¿¹¹æÀû ¼öÀÇÇÐÀÌ È®»êµÇ¸é¼­ Àü ¼¼°èÀûÀ¸·Î °í¾çÀÌ ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° »çÀ°·üÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϸ鼭 °í¾çÀÌ ¹éÇ÷º´ ¹ÙÀÌ·¯½º(FeLV), ±¤°ßº´, °í¾çÀÌ Ä®¸®½Ã ¹ÙÀÌ·¯½º(FCV)¿Í °°Àº Ä¡¸íÀûÀÎ Áúº´À¸·ÎºÎÅÍ ¹Ý·Áµ¿¹°À» º¸È£Çϱâ À§ÇØ Á¤±âÀûÀÎ ¹é½Å Á¢Á¾À» ¿ì¼±¼øÀ§¿¡ µÎ´Â º¸È£ÀÚµéÀÌ ´Ã°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° »ê¾÷ÀÌ ¿¹¹æÀû °Ç°­°ü¸®·Î ÀüȯÇÔ¿¡ µû¶ó ¹é½ÅÀº °í¾çÀÌ À£ºù °èȹÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ ¹× ºñÁ¤ºÎ±â±¸´Â ƯÈ÷ ±æ°í¾çÀÌ °³Ã¼¼ö°¡ ¸¹Àº Áö¿ª¿¡¼­ ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥À» Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù. Àμö°øÅëÀü¿°º´ ¿¹¹æ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±ÔÁ¦ ´ç±¹Àº ¹é½Å¿¡ ´ëÇÑ Á¢±Ù¼º°ú ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇϱâ À§ÇÑ °¡À̵å¶óÀÎÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº Àü¿°¼º °í¾çÀÌ Áúº´ÀÇ ¹ß»ýÀ» ¿¹¹æÇϱâ À§ÇØ ÇÙ½É ¿¹¹æÁ¢Á¾°ú ºñÇÙ½É ¿¹¹æÁ¢Á¾ÀÇ Á߿伺À» °­Á¶ÇÏ´Â ¼öÀÇ»çÇùȸ¿¡ ÀÇÇØ ´õ¿í µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.

¼öÀÇÇÐÀÇ ¹ßÀüÀº °í¾çÀÌ ¹é½Å¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆÀ»±î?

¼öÀÇÇÐ ºÐ¾ß¿¡¼­´Â ¹é½Å °³¹ßÀÌ Å©°Ô ¹ßÀüÇÏ¿© °í¾çÀÌ¿¡°Ô ´õ È¿°úÀûÀÌ°í ¿À·¡ Áö¼ÓµÇ´Â ¿¹¹æÁ¢Á¾ ¿É¼ÇÀÌ Á¡Á¡ ´õ ¸¹¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼ú°ú º¤ÅÍ ±â¹Ý ¹é½ÅÀº °í¾çÀÌ ¹é½ÅÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ°í ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÁÙÀÌ¸ç ´õ ¿À·¡ Áö¼ÓµÇ´Â ¸é¿ª·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î ¿©·¯ ¹ÙÀÌ·¯½º ±ÕÁÖ ¹× ¹ÚÅ׸®¾Æ¿¡ ´ëÇÑ ¿¹¹æ È¿°ú¸¦ Çâ»ó½ÃŲ »õ·Î¿î ¹é½ÅÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ°­ ¹é½Å°ú ºñº¸Á¶Á¦ ¹é½ÅÀÇ µµÀÔÀ¸·Î ÁÖ»ç ºÎÀ§ ¹ÝÀÀ¿¡ ´ëÇÑ ¿ì·Á°¡ ÇØ¼ÒµÇ¾î °í¾çÀÌ¿¡°Ô º¸´Ù Æí¾ÈÇÑ ¹é½Å Á¢Á¾ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¸é¿ªÇÐÀÇ ¹ßÀüÀº ¶ÇÇÑ °í¾çÀÌÀÇ ³ªÀÌ, °Ç°­ »óÅ ¹× »ýȰ ¹æ½Ä¿¡ ¸Â´Â ¹é½Å Á¢Á¾À» °¡´ÉÇϰÔÇÏ¿© °³º°È­ µÈ ¹é½Å Á¢Á¾ ÀÏÁ¤ÀÇ ±æÀ» ¿­¾ú½À´Ï´Ù. ¼öÀÇÇÐ »ý¸í°øÇÐÀÇ Áö¼ÓÀûÀÎ ¿¬±¸·Î ¹é½Å Á¦Á¦ ¹× Àü´Þ ¹æ¹ýÀÇ Áö¼ÓÀûÀÎ °³¼±À¸·Î ½ÃÀåÀº ÇýÅÃÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°í¾çÀÌ ¹é½ÅÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ½ÃÀå µ¿ÇâÀº ¹«¾ùÀΰ¡?

°í¾çÀÌ ¹é½Å ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä Æ®·»µå Áß Çϳª´Â È¥ÇÕ ¹é½Å¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. È¥ÇÕ ¹é½ÅÀº ÇÑ ¹øÀÇ Á¢Á¾À¸·Î ¿©·¯ Áúº´¿¡ ´ëÇÑ ¸é¿ª·ÂÀ» Á¦°øÇÔÀ¸·Î½á Á¾ÇÕÀûÀÎ º¸È£ È¿°ú¸¦ º¸ÀåÇÏ°í µ¿¹°º´¿øÀ» ¿©·¯ ¹ø ¹æ¹®ÇØ¾ß ÇÏ´Â ¹ø°Å·Î¿òÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä´Â °í¾çÀÌ¿¡°Ô Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¿¹¹æÁ¢Á¾ ¿É¼ÇÀ» ¿øÇÏ´Â º¸È£ÀÚµé »çÀÌ¿¡¼­ ƯÈ÷ ³ôÀº ÆíÀÔ´Ï´Ù. ¶Ç ´Ù¸¥ »õ·Î¿î Æ®·»µå´Â ¹Ý·Áµ¿¹° º¸Çè»ç³ª µ¿¹°º´¿ø¿¡¼­ Á¦°øÇÏ´Â ¿¹¹æ ¼öÀÇÇÐ ÆÐŰÁöÀÇ È®»êÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆÐŰÁö¿¡´Â Á¤±âÀûÀÎ ¹é½Å Á¢Á¾, Áø´Ü °Ë»ç, ±â»ýÃæ Á¦°Å°¡ Æ÷ÇԵǴ °æ¿ì°¡ ¸¹¾Æ ¹é½Å Á¢Á¾·üÀ» ³ôÀÌ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ¹Ý·Áµ¿¹° ÇコÄÉ¾î ºÐ¾ß¿¡¼­ E-Commerce°¡ È®»êµÇ¸é¼­ µ¿¹°¿ë ¹é½ÅÀÌ ´õ¿í Ä£¼÷ÇØÁ³°í, ¿Â¶óÀÎ Ç÷§ÆûÀº ÅÃ¹è ¹× Á¤±â ±¸¸Å ±â¹Ý ¹é½Å ¼­ºñ½º¸¦ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

°í¾çÀÌ ¹é½Å ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

°í¾çÀÌ ¹é½Å ½ÃÀåÀÇ ¼ºÀåÀº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, ¹é½Å ±â¼ú ¹ßÀü, °í¾çÀÌ Àü¿°º´ÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ µ¿¹° ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë´Â ¾çÁúÀÇ ¹é½Å Á¢Á¾ ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±ÇÏ¿© ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±¤°ßº´ ¿¹¹æÁ¢Á¾ ¹× ±âŸ °í¾çÀÌ Àü¿°º´ ¿¹¹æ ÇÁ·Î±×·¥¿¡ ´ëÇÑ ±ÔÁ¦ Àǹ«È­°¡ ¹é½Å º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ º¹Áö¿Í Ã¥ÀÓ°¨ ÀÖ´Â »çÀ°¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¤±âÀûÀÎ ¹é½Å Á¢Á¾ ÁؼöÀ²ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í¾çÀÌ Àü¿ë Áúº´¿¡ ´ëÇÑ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê°¡ È®´ëµÊ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ´õ È¿°úÀûÀÎ »õ·Î¿î ¹é½ÅÀÌ µµÀ﵃ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼öÀÇÇÐÀÌ °è¼Ó ¹ßÀüÇÏ´Â °¡¿îµ¥ °í¾çÀÌ ¹é½ÅÀº °í¾çÀÌ °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ³²¾Æ Àü ¼¼°è ±æ°í¾çÀÌ¿Í ±æ°í¾çÀÌ Áý´ÜÀÇ ÇູÀ» º¸ÀåÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

¹é½Å À¯Çü(°³·®/¾àµ¶È­ »ý¹é½Å, ºÒȰȭ ¹é½Å, ±âŸ ¹é½Å À¯Çü), Áúȯ(°í¾çÀÌ È£Èí±âÁúȯ, °í¾çÀÌ ¹éÇ÷º´ Áúȯ, °í¾çÀÌ ¹ü¹éÇ÷±¸ °¨¼ÒÁõ Áúȯ, °í¾çÀÌ ±¤°ßº´ Áúȯ, ±âŸ Áúȯ), Åõ¿© °æ·Î(ÁÖ»çÁ¦ Åõ¿© °æ·Î, °æºñ Åõ¿© °æ·Î), ¸é¿ª ±â°£(1³â ¸é¿ª ±â°£, 3³â ¸é¿ª ±â°£, ±âŸ ¸é¿ª ±â°£)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cat Vaccines Market to Reach US$1.7 Billion by 2030

The global market for Cat Vaccines estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Modified / Attenuated Live Vaccines, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$965.1 Million by the end of the analysis period. Growth in the Inactivated Vaccines segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$290.8 Million While China is Forecast to Grow at 12.8% CAGR

The Cat Vaccines market in the U.S. is estimated at US$290.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$369.7 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Cat Vaccines Market - Key Trends & Drivers Summarized

Why Is the Demand for Cat Vaccines Increasing?

The growing awareness of feline health and the increasing adoption of preventive veterinary care have significantly boosted the demand for cat vaccines worldwide. As pet ownership continues to rise, more cat owners are prioritizing regular vaccinations to protect their pets from life-threatening diseases such as feline leukemia virus (FeLV), rabies, and feline calicivirus (FCV). The shift toward preventative healthcare in the pet industry has made vaccines an essential component of feline wellness plans. Additionally, governmental and non-governmental organizations are actively promoting vaccination programs, particularly in regions with high stray cat populations. With an increased focus on zoonotic disease prevention, regulatory authorities are strengthening guidelines to ensure widespread vaccine accessibility and compliance. These efforts are further supported by veterinary associations emphasizing the importance of core and non-core vaccinations to prevent outbreaks of contagious feline diseases.

How Are Advancements in Veterinary Medicine Impacting Cat Vaccines?

The field of veterinary medicine is witnessing significant advancements in vaccine development, leading to more effective and long-lasting immunization options for cats. Recombinant DNA technology and vector-based vaccines are enhancing the efficacy and safety of feline vaccines, reducing the risk of adverse reactions while providing longer immunity. These innovations have led to the development of novel vaccines that offer improved protection against multiple strains of viruses and bacteria. Moreover, the introduction of intranasal and non-adjuvanted vaccines is addressing concerns over injection-site reactions, making vaccinations more comfortable for cats. Advances in immunology have also paved the way for personalized vaccination schedules, ensuring that feline vaccinations are tailored based on age, health status, and lifestyle factors. With ongoing research in veterinary biotechnology, the market is expected to benefit from continuous improvements in vaccine formulations and delivery methods.

What Market Trends Are Driving the Adoption of Cat Vaccines?

One of the major trends shaping the cat vaccine market is the increasing preference for combination vaccines. These formulations provide immunity against multiple diseases in a single dose, reducing the need for multiple veterinary visits while ensuring comprehensive protection. The demand for these vaccines is particularly high among pet owners who seek convenient and cost-effective immunization options for their cats. Another emerging trend is the rising adoption of preventive veterinary care packages offered by pet insurance providers and veterinary clinics. These packages often include routine vaccinations, diagnostic screenings, and parasite control measures, encouraging higher vaccine uptake. Additionally, the growing penetration of e-commerce in the pet healthcare sector is making veterinary vaccines more accessible, with online platforms facilitating home delivery and subscription-based vaccine services.

What Are the Key Growth Drivers in the Cat Vaccines Market?

The growth in the Cat Vaccines market is driven by several factors, including increasing pet ownership, advancements in vaccine technology, and the rising prevalence of feline infectious diseases. The expansion of veterinary healthcare infrastructure, particularly in emerging markets, is also contributing to market growth by improving access to high-quality vaccination services. Additionally, regulatory mandates for rabies vaccination and other feline disease prevention programs are fueling vaccine adoption. The growing focus on pet welfare and responsible pet ownership is leading to higher compliance rates for routine vaccinations. Furthermore, the expansion of research initiatives targeting feline-specific diseases is expected to introduce new and more effective vaccines in the coming years. As veterinary medicine continues to evolve, cat vaccines will remain a crucial component of feline healthcare, ensuring the well-being of domestic and stray cat populations globally.

SCOPE OF STUDY:

The report analyzes the Cat Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Modified/Attenuated Live Vaccines, Inactivated Vaccines, Other Vaccine Types); Disease (Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases, Other Diseases); Route of Administration (Injectables Route of Administration, Intranasal Route of Administration); Duration of Immunity (1 Year Duration of Immunity, 3 Years Duration of Immunity, Other Durations of Immunities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â